[Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes].
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) leading to demyelinization. Although our knowledge on the pathomechanism of MS has evolved dramatically in recent years; however there is still no effective cure for MS. So far, non-specific immune suppressive agents are used to slow down the disease. Recently, there are many efforts to find a new method that would allow to control specifically unwanted immune response. It might be achieved by affecting antigen recognition or induction of "immune deviation".
Szczepanik
Marian
M
Zakład Biologii Rozwoju Człowieka Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie. mmszczep@cyf-kr.edu.pl
Tutaj
Monika
M
Filipczak-Bryniarska
Iwona
I
Bryniarski
Krzysztof
K
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents